ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240,882 | -18.1% | 44,199 | +0.9% | 0.13% | -19.3% |
| Q2 2023 | $294,049 | -21.5% | 43,823 | +3.3% | 0.16% | -26.5% |
| Q1 2023 | $374,670 | +19.1% | 42,432 | +3.0% | 0.22% | +7.9% |
| Q4 2022 | $314,703 | +11.6% | 41,192 | +3.9% | 0.20% | +8.0% |
| Q3 2022 | $282,000 | +141.0% | 39,658 | +173.5% | 0.19% | +113.6% |
| Q2 2022 | $117,000 | -41.5% | 14,500 | +0.8% | 0.09% | -27.9% |
| Q1 2022 | $200,000 | -50.1% | 14,387 | +0.6% | 0.12% | -45.8% |
| Q4 2021 | $401,000 | -18.5% | 14,297 | -1.2% | 0.22% | -19.1% |
| Q3 2021 | $492,000 | -18.1% | 14,470 | -1.6% | 0.28% | -18.0% |
| Q2 2021 | $601,000 | +2.0% | 14,711 | +0.5% | 0.34% | -10.3% |
| Q1 2021 | $589,000 | -32.1% | 14,636 | -0.3% | 0.38% | -38.6% |
| Q4 2020 | $868,000 | – | 14,683 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |